What certifications do Indian pharmaceutical exporters need to supply Saudi Arabia?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Saudi Arabia pharmaceutical trade?

$22.0K per consignment across 6,563 shipments.

How many Indian pharmaceutical companies export to Saudi Arabia?

215 Indian companies. Largest: CIPLA LIMITED with $33.4M.

How can I find verified Indian pharmaceutical suppliers for Saudi Arabia?

TransData Nexus covers 215 active exporters with shipment history and trade values at transdatanexus.com.

India to Saudi Arabia Pharmaceutical Export (2026) — $144.7M, 215 Suppliers | TransData Nexus

India to Saudi Arabia Pharmaceutical Export (2026) — $144.7M, 215 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Saudi Arabia

#	Formulation	Value	Share
1	Pulmirema Respules 0.25mg/ml (6960packx12x5=417600 )(2ml)	$4.8M	3.3%
2	Pulmirema Respules 0.25mg/ml (6912 Packx12x5=414720 )(2 Ml)	$4.7M	3.3%
3	Pulmirema Respules 0.25mg/ml (6,888 Pack X 12x5=413280 )(2ml)	$4.7M	3.3%
4	Pulmirema Respules 0.25mg/ml (6,888 Pack X 12x5 = 413280 )	$4.7M	3.3%
5	Pulmirema Respules 0.5mg/ml (3,024 Pack X12x5=181440 )(2ml)	$3.3M	2.3%
6	Pulmirema Respules 0.5mg/ml (2,976 Pack X12x5=178560 )(2ml)	$3.2M	2.2%
7	Mirel Kit Reteplase Mirel Reteplase Recombinant Tissue Plasminogen Activator Ki…	$2.9M	2.0%
8	Mebeverine Hcl Sr Pellets 80%	$2.8M	2.0%
9	Low Molecular Weight Heparin Enoxaparinsodium Injection Usp, 40mg in 0.4ml Pre-…	$2.2M	1.5%
10	Low Molecular Weight Heparin Enoxaparinsodium Injection Usp,80mg in 0.8ml Pre-f…	$1.9M	1.3%
11	Low Molecular Weight Heparin Enoxaparinsodium Injection USP 80mg in 0.8ml Pre-f…	$1.9M	1.3%
12	Low Molecular Weight Heparin Enoxaparinsodium Injection USP 40mg in 0.4ml Pre-f…	$1.6M	1.1%
13	Plerixafor 20mg (1x1) Boston -sa	$1.6M	1.1%
14	Mirel Kit (reteplase) Mirel Reteplase -recombinant Tissue Plasminogen Activator…	$1.5M	1.1%
15	Pharma : Hamsyl 3750 IU Injection - 1 Vial (inv. No.: 2405200003 Dt. 15.05.2024)	$1.1M	0.8%

India exports 20+ pharmaceutical formulations to Saudi Arabia with a combined trade value of $144.7M. Key products include Sorafenib ($1.1M), Everolimus ($1.0M), Esomeprazole ($985K). These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 6,563 verified Indian Customs (DGFT) shipment records.

Top Pharmaceutical Products — India to Saudi Arabia Trade Routes

1Sorafenib$1.1M 2Everolimus$1.0M

3Esomeprazole$985K

These are the top pharmaceutical products exported from India to Saudi Arabia, each with a dedicated trade route analysis page. Click any product to see detailed export data including Indian suppliers, Saudi Arabia buyers, regulatory requirements, and logistics for that specific product corridor. Products include Sorafenib ($1.1M), Everolimus ($1.0M), Esomeprazole ($985K) — all finished pharmaceutical formulations verified from Indian Customs (DGFT) records.

Top Indian Exporters to Saudi Arabia

1Cipla Limited

$33.4M

2Gland Pharma Ltd

$16.3M

3Msn Laboratories Private Limited

$12.9M

4Venus Remedies Limited

$7.6M

5Glenmark Pharmaceuticals Limited

Port Analysis — India to Saudi Arabia Pharmaceutical Shipments

Indian Export Ports

DELHI AIR5.5%

HYDERABAD AIR3.4%

HYDERABAD ACC (INHYD4)3.4%

SAHAR AIR CARGO ACC (INBOM4)15.0%

HYDERABAD ICD1.4%

Saudi Arabia Import Ports

RIYADH51.9%

JEDDAH25.8%

Dammam3.1%

DAMMAM4.0%

Riyadh3.2%

Trade Statistics

Total Value$144.7M

Shipments6,563

Indian Exporters215

Saudi Arabia Buyers374

Avg Shipment$22K

Products4,587

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B

Last updated: March 28, 2026

What is the total value of India's pharmaceutical export to Saudi Arabia?

India exported pharmaceuticals worth $144.7M to Saudi Arabia across 6,563 verified shipments.

Who are the top Indian pharmaceutical exporters to Saudi Arabia?

1. CIPLA LIMITED — $33.4M. 2. GLAND PHARMA LTD — $16.3M. 3. MSN LABORATORIES PRIVATE LIMITED — $12.9M. Total: 215 suppliers.

Which companies in Saudi Arabia import pharmaceuticals from India?

1. BOSTON ONCOLOGY ARABIA — $30.0M. 2. TO THE ORDER OF RIYAD BANK — $25.7M. 3. S T C — $6.8M. 374 buyers total.

What pharmaceutical products does India export most to Saudi Arabia?

1. Pulmirema Respules 0.25mg/ml (6960packx12x5=417600 )(2ml) ($4.8M, 3.3%); 2. Pulmirema Respules 0.25mg/ml (6912 Packx12x5=414720 )(2 Ml) ($4.7M, 3.3%); 3. Pulmirema Respules 0.25mg/ml (6,888 Pack X 12x5=413280 )(2ml) ($4.7M, 3.3%); 4. Pulmirema Respules 0.25mg/ml (6,888 Pack X 12x5 = 413280 ) ($4.7M, 3.3%); 5. Pulmirema Respules 0.5mg/ml (3,024 Pack X12x5=181440 )(2ml) ($3.3M, 2.3%)

Which ports handle pharmaceutical shipments from India to Saudi Arabia?

Export: DELHI AIR, HYDERABAD AIR, HYDERABAD ACC (INHYD4), SAHAR AIR CARGO ACC (INBOM4), HYDERABAD ICD. Import: RIYADH, JEDDAH, Dammam, DAMMAM, Riyadh.

Why does Saudi Arabia import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $144.7M corridor reflects quality compliance and pricing advantages.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Saudi Arabia identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 6,563 verified shipments from 215 Indian exporters to 374 Saudi Arabia buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

215 Exporters

374 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Saudi Arabia Pharmaceutical Export